Mistabron 600mg Respirator Solution


Product Info

Prescription required Yes
Marketer Dr Reddy's Laboratories Ltd
Active Ingredient Mesna (600mg)
Storage Store below 30°C
Chemical ClassSulfhydryl compound, {organosulfonic acid}
Habit FormingNo
Therapeutic ClassBLOOD RELATED
Action ClassCytoprotective agents- Bladder
User Rating4.8
User Reviews399

FAQ

Question
Is Mistabron 600mg Respirator Solution a vesicant?
No, Mistabron 600mg Respirator Solution is not a vesicant.
Answer

Question
Is Mistabron 600mg Respirator Solution a chemotherapy drug?
Mistabron 600mg Respirator Solution is not a chemotherapy drug
Answer

Question
Is Mistabron 600mg Respirator Solution cytotoxic?
No. Mistabron 600mg Respirator Solution is not cytotoxic drug. It is cytoprotective drug
Answer

Question
Why it is given with ifosamide or cyclophosphamise (Cytoxan)?
It is given along with the chemotherapy drug ifosfamide or cyclophosphamide to reduce the side effects of these drugs
Answer

Question
Is mesna compatible with potassium chloride and doxorubicin?
Yes, Mesna is compatible with potassium chloride and doxorubicin
Answer

Mistabron 600mg Respirator Solution Reviews

Mistabron 600mg Respirator Solution is a medicine used to prevent bleeding into the urine by a specific anticancer medicine known as ifosfamide (ifosfamide-induced hemorrhagic cystitis). It helps to reduce the risk of inflammation and bleeding in the bladder, who receive this anticancer medicine.

Mistabron 600mg Respirator Solution is give under the supervision of doctor. It is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your need and response to treatment. You may be asked for regular blood tests and urine test while taking this medication. It is important to inform your doctor if you are pregnant or planning to become pregnant or are breastfeeding.

You should seek immediate medical attention if you experience severe allergic reactions like rash, itching, breathing difficulty, chest tightness and swelling of the mouth, face, lips, or tongue while taking Mistabron 600mg Respirator Solution. It is better to drink at least 1 litre of fluid daily while you are receiving this medicine. You should not drive or operate machinery as it may cause drowsiness, dizziness, or blurred vision.

How Mistabron 600mg Respirator Solution Works

Mistabron 600mg Respirator Solution helps to reduce the risk of inflammation and bleeding in the bladder, who receive ifosfamide (a medicine used to treat cancer).

How to Use Mistabron 600mg Respirator Solution

Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Twist off the top of the respule/transpule and squeeze all the liquid into the nebulizer. It should be used right away after opening.

Uses of Mistabron 600mg Respirator Solution

  • Ifosfamide-induced hemorrhagic cystitis

Mistabron 600mg Respirator Solution Side Effects

Item form

Safety Tips

Breast feeding  UNSAFE
Mistabron 600mg Respirator Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy  SAFE IF PRESCRIBED
Mistabron 600mg Respirator Solution is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Alcohol  CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Mistabron 600mg Respirator Solution. Please consult your doctor.

Quick Tips

  • Mistabron 600mg Respirator Solution is given as in injection or infusion under the supervision of a doctor only.
  • Your doctor may get a regular urine and blood tests done to monitor your blood cell count (CBC).
  • Use an effective method of birth control to avoid pregnancy while taking this medication.
  • It is advisable to drink plenty of water to stay hydrated while taking this medicine.
  • Do not skip any dose and complete the course as suggested by your doctor.

References

  1. Mesna. Los Angeles, California: American pharmaceutical partners; 2001.
  2. Mesna. Thetford, Norfolk: Baxter Healthcare Ltd.; 2003 [revised Oct. 2014].
  3. Medscape. Mesna.
  4. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 870-71.

Other Medical Preparations